Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Roche says Hemlibra effective in pivotal study

December 3, 2018 7:41 PM
110 0

ZURICH (Reuters) - Roche’s Hemlibra provided sustained bleed control in the largest pivotal study to date of children with a form of haemophilia, the Swiss drugmaker said on Monday.

Nearly 77 percent of children receiving Hemlibra once weekly experienced no treated bleeds, while Hemlibra once weekly reduced treated bleeds by 99 percent compared to prior bypassing agents, it said in a statement. Hemlibra every two weeks and every four weeks also showed clinically meaningful cont...

Read more

Share in social networks:

Comments - 0